Revolutionizing therapy for people living with cancer
Honesty, respect, and trust guide us
Premier science empowers our passion
Shared dedication and diverse perspectives drive successful collaborations
Entrepreneurial spirit advances breakthrough therapies
By working together to our full potential, we make a real difference in the world
Seagen is a global biotechnology company that develops and commercializes transformative cancer therapies. We’re driven by a singular mission—to make a difference for people impacted by cancer.
As an industry leader in antibody–drug conjugate (ADC) technology, we pioneered the science of harnessing antibodies designed to deliver cell-killing agents to cancer cells. Three of our four approved medicines are built on this technology.
We also focus our research efforts on novel targeted small molecule therapies. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents.
We are a multinational multicultural company committed to diversity, equity, and inclusion. Our cutting edge therapies impact the lives of people of all races, ethnicities, ages, physical abilities, gender identities, and sexual orientations, and we work hard to have our employees reflect the people we serve. Learn more about Diversity, Equity, and Inclusion at Seagen and get information about our employee resource networks.
Seagen is committed to securing patient access to our medicines. Seagen therapies are priced based on the value delivered to patients, providers, and healthcare systems, and in support of our mission to advance the innovation of targeted cancer medicine – potentially giving patients the gift of time by improving and extending their lives.